Movers and Shakers
UK headquartered biopsy company, Angle has appointed Jan Groen as a non-executive director. Groen is currently president and CEO of MDxHealth, a Euronext listed molecular diagnostic company that develops tests for urological and other cancers.
Movers and Shakers
Tim Gatzenmeier from the Max-Planck-Institut für Kohlenforschung, Mulheim, Germany, has been awarded the $3,000 grand prize in Merck’s Alfred R. Bader Award
Movers and Shakers
US biopharmaceutical company Acorda Therapeutics, which focuses on neurological therapies, is losing its CTO Rick Batycky after 20 years’ service.
Movers and Shakers
US biopharma company Acceleron Pharma, based in Cambridge, MA, has appointed Robert K. Zeldin as CMO.
Movers and shakers
Biotechnology company Abcam, headquartered in Cambridge, UK, has appointed Peter Allen as non-executive chairman
Movers and Shakers
US biopharmaceutical company Achillion Pharmaceuticals has appointed Joseph Truitt as CEO and member of the board.
Movers and Shakers
US biopharmaceutical company Abeona Therapeutics has appointed Carsten Thiel as CEO.
Movers and Shakers
US immunotherapy company, Aduro Biotech, headquartered in Berkeley, California, has promoted Hans van Eenennaam to executive vp of antibody research and site head of Aduro Biotech Europe.
Movers and Shakers
California-based biotechnology company Alkahest, which specialises in developing treatments for neurodegenerative diseases and other age-related conditions, has appointed Karl G. Trass as vp for regulatory affairs.
People
US headquartered Aerie Pharmaceuticals, which focuses on therapies for diseases of the eye, has appointed Nhi Ong as director of analytics